TEACHERS ADVISORS, LLC - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 1 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$166,000
+18.6%
123,9120.0%0.00%
Q4 2018$140,000
-71.8%
123,912
-31.2%
0.00%
Q3 2018$496,000
+52.6%
180,010
+98.0%
0.00%
Q2 2018$325,000
+16.5%
90,9240.0%0.00%
Q1 2018$279,000
-51.3%
90,9240.0%0.00%
-100.0%
Q4 2017$573,000
+10.4%
90,924
+19.9%
0.00%0.0%
Q3 2017$519,000
+8.4%
75,863
+13.0%
0.00%0.0%
Q2 2017$479,000
-31.3%
67,136
-11.5%
0.00%0.0%
Q1 2017$697,000
+127.8%
75,8440.0%0.00%
Q4 2016$306,000
+26.4%
75,844
+20.1%
0.00%
Q3 2016$242,000
-4.3%
63,153
+7.2%
0.00%
Q2 2016$253,000
-49.2%
58,899
-45.2%
0.00%
-100.0%
Q1 2016$498,000
-51.3%
107,573
+5.5%
0.00%
-50.0%
Q4 2015$1,022,000
+34.5%
101,9230.0%0.00%0.0%
Q3 2015$760,000
-72.9%
101,923
+72.6%
0.00%
-60.0%
Q2 2015$2,801,000
+82.4%
59,036
+40.9%
0.01%
+66.7%
Q1 2015$1,536,000
+6.5%
41,910
+15.4%
0.00%0.0%
Q4 2014$1,442,000
+134.5%
36,319
+17.9%
0.00%
+200.0%
Q3 2014$615,000
+47.8%
30,8050.0%0.00%0.0%
Q2 2014$416,000
+104.9%
30,805
+65.6%
0.00%
Q1 2014$203,000
+1.5%
18,605
+25.8%
0.00%
Q4 2013$200,000
+19.0%
14,7950.0%0.00%
Q3 2013$168,000
+60.0%
14,795
-0.6%
0.00%
Q2 2013$105,00014,8870.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 1,048,642$3,219,0000.50%
Virtus ETF Advisers LLC 130,920$402,0000.35%
683 Capital Management, LLC 600,000$1,842,0000.16%
Tekla Capital Management LLC 859,322$2,638,0000.10%
DOW CHEMICAL CO /DE/ 65,000$200,0000.07%
Alambic Investment Management, L.P. 115,834$356,0000.05%
A.R.T. Advisors, LLC 262,896$807,0000.03%
Candriam S.C.A. 520,613$1,598,0000.03%
Man Group plc 1,674,341$5,140,0000.02%
Baker Brothers Advisors 935,000$2,870,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders